Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer

ABSTRACT: The primary objective is to determine the maximum tolerated dose/recommended phase II dose of the combination regimen of NK012 and 5-fluorouracil in patients with advanced solid tumors.

DISEASE(S): Metastatic Colorectal Cancer,Advanced Solid Tumors,Colorectal Cancer,Colorectal Neoplasms,Solid Tumors

PROVIDER: 2097924 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR